These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 796485)

  • 1. [Comparative results of cephacetrile with cefazolin in complicated urinary tract infections by means of double-blind trials (author's transl)].
    Ishigami J; Mita T; Tanikaze S; Fujii A; Kuroda M
    Jpn J Antibiot; 1976 Dec; 29(12):1052-69. PubMed ID: 796485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical evaluation of the effect of cephacetrile on bacterial pneumonia. A comparative test with cefazolin by a double blind method (author's transl)].
    Matsumoto K; Noguchi Y; Uzuka Y; Kato Y; Saito A
    Jpn J Antibiot; 1976 Dec; 29(12):1070-92. PubMed ID: 796486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on cefmetazole and cefazolin in the treatment of suppurative otitis media].
    Baba S; Ito H; Kinoshita H; Murai K; Wada K; Sambe B; Kawamura S; Sugita R; Fujimaki Y; Kataura A; Sambe S; Watanabe H; Ikeda T; Nameki H; Tanaka M; Osawa H; Ikeda Y; Kawakubo J; Okuda M; Kamio T; Yagi T; Sekine S; Watanabe Y; Nomura Y; Miyakawa K; Yamaguchi H; Totsuka M; Kamio T; Yuge K; Nakamura K; Kubota T; Nakagawa T; Nakagawa M; Komatsuzaki A; Osafune H; Kojima S; Sakamoto Y; Honmura Y; Nakano Y; Imai A; Miyao M; Honda H; Iwasaki E; Iguchi M; Ikeda M; Hondoh J; Noda M; Umeda K; Maruo T; Deguchi K
    Jpn J Antibiot; 1982 Jun; 35(6):1523-52. PubMed ID: 6752467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental and clinical studies on cefuzoname in the pediatric field].
    Toyonaga Y; Sugita M; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefazolin efficacy and antibiotic sensitivity against pathogenic bacteria in pediatric with acute upper urinary tract infection].
    Fuke T; Abe Y; Hoshino A; Oto H; Sakai N; Murayama J; Yoshida K; Itabashi K
    Kansenshogaku Zasshi; 2010 May; 84(3):269-75. PubMed ID: 20560417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sugita M; Takahashi T; Fukushima Y; Yamasaki M; Hori M
    Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory and clinical studies on cefoxitin in the field of obstetrics and gynecology (author's transl)].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1978 Jun; 31(6):315-24. PubMed ID: 355681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
    Jpn J Antibiot; 1987 Dec; 40(12):2026-142. PubMed ID: 3448256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative test of the effectiveness of cefoperazone (T-1551) and cefazolin (CEZ) on respiratory tract infection by double blind method (II) (author's transl)].
    Kansenshogaku Zasshi; 1980 Dec; 54(12):798-835. PubMed ID: 6454732
    [No Abstract]   [Full Text] [Related]  

  • 13. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cefazolin in 45 cases of urinary tract infections.
    Lus RG; Calvo MC; Lopez LG; Cancer RC; Molina AM; Sanchez ED; Parilla AC; Mur LL
    Chemotherapy; 1977; 23(2):106-113. PubMed ID: 318980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study.
    Iversen P; Madsen PO
    Clin Ther; 1981; 4(4):302-7. PubMed ID: 7037184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical studies of flomoxef].
    Nozue N; Ueda Y; Haga T; Muraoka A; Ono Y; Nishiya H; Miyashita H
    Jpn J Antibiot; 1987 Oct; 40(10):1774-86. PubMed ID: 3327964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
    Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
    Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.